GSK plc
XETRA:GS71

Watchlist Manager
GSK plc Logo
GSK plc
XETRA:GS71
Watchlist
Price: 20.98 EUR -1.59% Market Closed
Market Cap: 85.6B EUR

Wall Street
Price Targets

GS71 Price Targets Summary
GSK plc

Wall Street analysts forecast GS71 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GS71 is 21.69 EUR with a low forecast of 16.93 EUR and a high forecast of 31.1 EUR.

Lowest
Price Target
16.93 EUR
19% Downside
Average
Price Target
21.69 EUR
3% Upside
Highest
Price Target
31.1 EUR
48% Upside
GSK plc Competitors:
Price Targets
1477
Ocumension Therapeutics
43% Upside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
37% Upside
600285
Henan Lingrui Pharmaceutical Co Ltd
39% Upside
600085
Beijing Tongrentang Co Ltd
36% Upside
ACUTAAS
Acutaas Chemicals Ltd
10% Upside
1681
Consun Pharmaceutical Group Ltd
12% Upside
IPCALAB
IPCA Laboratories Ltd
6% Upside
LLY
Eli Lilly and Co
9% Upside

Revenue
Forecast

Revenue Estimate
GSK plc

For the last 13 years the compound annual growth rate for GSK plc's revenue is 1%. The projected CAGR for the next 4 years is 5%.

1%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
GSK plc

For the last 13 years the compound annual growth rate for GSK plc's operating income is 0%. The projected CAGR for the next 4 years is 12%.

0%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
GSK plc

For the last 13 years the compound annual growth rate for GSK plc's net income is -5%. The projected CAGR for the next 4 years is 16%.

-5%
Past Growth
16%
Estimated Growth
Estimates Accuracy
55%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GS71's stock price target?
Price Target
21.69 EUR

According to Wall Street analysts, the average 1-year price target for GS71 is 21.69 EUR with a low forecast of 16.93 EUR and a high forecast of 31.1 EUR.

What is GSK plc's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for GSK plc's revenue is 1%. The projected CAGR for the next 4 years is 5%.

What is GSK plc's Operating Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for GSK plc's operating income is 0%. The projected CAGR for the next 4 years is 12%.

What is GSK plc's Net Income forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for GSK plc's net income is -5%. The projected CAGR for the next 4 years is 16%.

Back to Top